Ipilimumab/NivolumabHyperthyroidism and hypophysitis

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2024年 / 2006卷 / 1期
关键词：
D O I：
10.1007/s40278-024-58237-8
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：342 / 342
相关论文
共 50 条
  • [41] Ipilimumab-induced autoimmune hypophysitis: a differential for sellar mass lesions
    Rodrigues, Beverly T.
    Otty, Zulfiquer
    Sangla, Kunwarjit
    Shenoy, Vasant V.
    [J]. ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS, 2014,
  • [42] A Rare Case of Ipilimumab Induced Pituitary Hypophysitis: An Evolving Clinical Entity
    Buddhdev, Kajalben
    Buddhdev, Bhuvin Mukesh
    [J]. ENDOCRINE REVIEWS, 2014, 35 (03)
  • [43] Ipilimumab-induced hypophysitis in melanoma patients: an Australian case series
    Lam, T.
    Chan, M. M. K.
    Sweeting, A. N.
    De Sousa, S. M. C.
    Clements, A.
    Carlino, M. S.
    Long, G. V.
    Tonks, K.
    Chua, E.
    Kefford, R. F.
    Chipps, D. R.
    [J]. INTERNAL MEDICINE JOURNAL, 2015, 45 (10) : 1066 - 1073
  • [44] Adrenal insufficiency secondary to ipilimumab induced hypophysitis: the Northern Irish experience
    Todd, A.
    Wallace, I
    Thiraviaraj, A.
    Oladipo, B.
    Nugent, A.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2016, 185 : 409 - 409
  • [45] Fall in TSH by ≥80% is associated with development of ipilimumab-induced hypophysitis
    Sheriff, Nisa
    De Sousa, Sunita M. C.
    Menzies, Alexander M.
    Tsang, Venessa H. M.
    Long, Georgina V.
    Tonks, Katherine T.
    [J]. CLINICAL ENDOCRINOLOGY, 2017, 86 : 36 - 36
  • [46] Hypophysitis Caused by Ipilimumab in Cancer Patients: Hormone Replacement or Immunosuppressive Therapy
    Lammert, A.
    Schneider, H. J.
    Bergmann, T.
    Benck, U.
    Kraemer, B. K.
    Gaertner, R.
    Metzner, C.
    Schoefl, C.
    Berking, C.
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2013, 121 (10) : 581 - 587
  • [47] Ipilimumab/nivolumabThyroiditis, hypophysitis and fulminant type-1 diabetes mellitus
    [J]. Reactions Weekly, 2024, 2007 (1) : 196 - 196
  • [48] Managing Ipilimumab-Induced Hypophysitis: Challenges and Current Therapeutic Strategies
    Tsoli, Marina
    Kaltsas, Gregory
    Angelousi, Anna
    Alexandraki, Krystallenia
    Randeva, Harpal
    Kassi, Eva
    [J]. CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 9551 - 9561
  • [49] Autoimmune hypophysitis is a marker of favorable outcome during treatment of melanoma with ipilimumab
    Eatrides, Jennifer M.
    Weber, Jeffrey
    Egan, Kathleen
    Acierno, Marjorie
    Schell, Michael
    Lillienfeld, Howard
    Creelan, Ben
    [J]. CANCER RESEARCH, 2015, 75
  • [50] Ipilimumab treatment associated pituitary hypophysitis: Clinical presentation and imaging diagnosis
    Chodakiewitz, Yosef
    Brown, Sanford
    Boxerman, Jerrold L.
    Brody, Jeffrey M.
    Rogg, Jeffrey M.
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2014, 125 : 125 - 130
12345